AP2006003578A0 - Pharmaceutical formulations, methods and dosing regimens for the treatment and prevention of acute coronary syndromes. - Google Patents

Pharmaceutical formulations, methods and dosing regimens for the treatment and prevention of acute coronary syndromes.

Info

Publication number
AP2006003578A0
AP2006003578A0 AP2006003578A AP2006003578A AP2006003578A0 AP 2006003578 A0 AP2006003578 A0 AP 2006003578A0 AP 2006003578 A AP2006003578 A AP 2006003578A AP 2006003578 A AP2006003578 A AP 2006003578A AP 2006003578 A0 AP2006003578 A0 AP 2006003578A0
Authority
AP
ARIPO
Prior art keywords
prevention
treatment
methods
pharmaceutical formulations
acute coronary
Prior art date
Application number
AP2006003578A
Inventor
Charles L Bisgaier
Daniel Artman
Narendra Lalwani
Original Assignee
Esperion Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esperion Therapeutics Inc filed Critical Esperion Therapeutics Inc
Priority claimed from PCT/US2004/034800 external-priority patent/WO2005041866A2/en
Publication of AP2006003578A0 publication Critical patent/AP2006003578A0/en

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
AP2006003578A 2003-10-20 2004-10-19 Pharmaceutical formulations, methods and dosing regimens for the treatment and prevention of acute coronary syndromes. AP2006003578A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51311603P 2003-10-20 2003-10-20
PCT/US2004/034800 WO2005041866A2 (en) 2003-10-20 2004-10-19 Pharmaceutical formulations, methods and dosing regimens for the treatment and prevention of acute coronary syndromes

Publications (1)

Publication Number Publication Date
AP2006003578A0 true AP2006003578A0 (en) 2006-04-30

Family

ID=37444404

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2006003578A AP2006003578A0 (en) 2003-10-20 2004-10-19 Pharmaceutical formulations, methods and dosing regimens for the treatment and prevention of acute coronary syndromes.

Country Status (5)

Country Link
CN (1) CN1870894B (en)
AP (1) AP2006003578A0 (en)
IS (1) IS8356A (en)
TN (1) TNSN06114A1 (en)
ZA (1) ZA200602248B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2793913B1 (en) * 2011-12-21 2023-06-21 CSL Limited Dosage regime for apolipoprotein formulations
CN105483076B (en) * 2015-12-23 2019-01-25 中国科学院生物物理研究所 A kind of preparation method and applications of fat-body

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8625435D0 (en) * 1986-10-23 1986-11-26 Erba Farmitalia Human apolipoprotein ai
IT1229996B (en) * 1989-04-20 1991-09-20 Cesare Sirtori EXPRESSION OF APOLIPOPROTEIN AI AND APOLIPOPROTEIN AI-MILAN IN YEAST AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE APOLIPOPROTEINS.
SE9603304D0 (en) * 1996-09-11 1996-09-11 Pharmacia & Upjohn Ab Process for purifying a compound
PL372925A1 (en) * 2001-09-28 2005-08-08 Esperion Therapeutics Inc. Prevention and treatment of restenosis by local administration of drug

Also Published As

Publication number Publication date
CN1870894A (en) 2006-11-29
IS8356A (en) 2006-03-16
CN1870894B (en) 2011-08-10
TNSN06114A1 (en) 2007-11-15
ZA200602248B (en) 2007-09-26

Similar Documents

Publication Publication Date Title
IL174301A0 (en) Pharmaceutical formulations, methods and dosing regimens for the treatment and prevention of acute coronary syndromes
AP2006003596A0 (en) A pharmaceutical composition for the treatment of cardiovascular and cerebrovascular diseases.
MXPA03006884A (en) Pharmaceutical formulation.
WO2004006858A3 (en) Compounds, compositions, and methods employing same
TWI347201B (en) Pharmaceutical products,uses thereof and methods for preparing the same
PL400027A1 (en) Multielement pharmaceutical dosage form and process for the preparation thereof
IL230815A (en) Diketopiperazine compounds, pharmaceutical compositions comprising the same and use thereof for treating t-cell mediated diseases
IL176005A0 (en) 2,6-bisheteroaryl-4-aminopyrimidine derivatives and pharmaceutical compositions containing the same
IS7735A (en) Benzodiazepine derivatives and pharmaceutical compositions containing them.
MXPA03007641A (en) Pharmaceutical formulation.
IL165977A (en) Substituted pyrimidinylaminobenzamides , process for the preparation thereof and pharmaceutical compositions comprising the same
MXPA03007215A (en) Pharmaceutical formulations.
HK1084124A1 (en) Novel aromatic fluoroglycoside derivatives, pharmaceutical products containing said compounds and the use thereof
ZA200706254B (en) 18-methyl-19-nor-17-pregn-4-en-21,17-carbolactones and pharmaceutical preparations comprising the same
AP2005003382A0 (en) Liquid pharmaceutical formulations of palonosetron.
IT1318649B1 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF MUCOSITES AND STOMATITIS.
EP1577317A4 (en) Nitrogen-containing heterocycic derivatives, medicinal compositions containing the same and medicinal use thereof
ZA200410211B (en) Quinuclidine derivatives and pharmaceutical compositions containing the same.
IL174479A (en) Hemiasterlin derivatives, pharmaceutical compositions comprising the same and uses thereof
PL394604A1 (en) Vinylazocycloalkanyl derivative, the use thereof and pharmaceutical composition
MXPA02012249A (en) Peptides, compositions and methods for the treatment of burkholderia cepacia.
AP2005003362A0 (en) Formulation and methods for the treatment of thrombocythemia.
IL181216A0 (en) 3, 5-seco-4-norcholestane derivatives and pharmaceutical compositions containing the same
ITBO20030486A1 (en) GRANULATOR DEVICE FOR THE TREATMENT OF POWDERED PRODUCTS.
PL374761A1 (en) N-benzodioxolyl, n-benzodioxanyl and n-benzodioxepinyl arylcarbonxamide derivatives, and pharmaceutical compositions comprising them